RSMSSB PTI Recruitment 2022 over 5546 vacancies; View all details
The Rajasthan Subordinate and Ministerial Services Selection Board (RSMSSB), has announced the RSMSSB PTI Recruitment 2022.
US approves Covid vaccine for children aged 6 months to 5 years
The US Food and Drug Administration granted emergency authorization June 17 for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children.
India Post Payments Bank will tie up with WhatsApp to offer services
the central government is considering a partnership between the India Post Payments Bank and the leading messaging platform WhatsApp to provide a variety of banking and financial services.
No more Power Cuts in the country due to coal shortage
Coal minister Pralhad Joshi on June 17 assured that there would be no power cuts in the country from now onwards due to coal shortage.
State announced that Agniveers will be given priority in state police posts
Several states have announced that they will give priority to 'Agniveers' in recruitment to police and related services in their states.
Indian Restaurant in US won America’s most prestigious culinary awards
A top culinary prize was recently given to an Indian restaurant in the United States.
Mere Papa: My Hero!
समय के चक्र में हर चीज अपना स्वरूप बदलती है। बदलाव ही प्रकृति का नियम है। लेकिन इसी प्रकृति ने एक रिश्ते को सभी बदलावों से परे रखा है। वो है माता-पिता और उनके बच्चों का रिश्ता।
How ‘Aspire For Her’ aims to bridge Gender Gap in India’s Workforce
Madhura Dasgupta, an ex-banker, founded 'Aspire For Her' with the goal of making financially independent women by turning their career aspiration into action.
Indonesia Opens 2022: HS Prannoy storms into semi-final after defeating Denmark’s Rasmus Gemke
HS Prannoy, India's Thomas Cup hero, extended his impressive run in Jakarta as the World No. 23 on June 17, reaching the semi-finals of the Indonesia Open Super 1000 tournament.
Covaxin proven safe for children of 2-18 years age group in phase II/III study
Bharat Biotech International Ltd announced on June 17 that its COVID-19 vaccine Covaxin was safe, well-tolerated, and highly immunogenic in children and adolescents aged 2 to 18 years in a phase II/III study.
